scorecardresearch
Wednesday, October 2, 2024
TopicCOVID-19

Topic: COVID-19

Centre discontinues allocation of Remdesivir to states as supply improves

Union Minister Mansukh L Mandaviya said supply of the drug, which is being used to treat Covid-19, has been ramped up over ten times since 11 April.

SubscriberWrites: Modi govt must drop its hubris, accept mistakes and give a fresh shot at procuring vaccines

Since it was Modi who took the credit for India being a saviour to the world at international forums, the blame must also be his.

SubscriberWrites: How Covid increased malnutrition, especially in children, and is crisis of the future

Whether we win or lose the war against Covid, we risk losing children to acute malnutrition, diarrhea, pneumonia and other illnesses, writes Rajpal Bijarnia.

Why everyone won’t be happy with GST relief on Covid related items

Exemption given from IGST extended to even paid imports of Covid relief material, is likely to benefit NGOs recognised by states. But many others will be left out.

Covaxin production to be increased to 6-7 crore doses in July-August, health ministry says

The health ministry said the production capacity of Bharat Biotech's Covaxin is expected to reach nearly 10 crore doses a month by September.

India risks becoming Latin America on the ‘Great Gatsby Curve’, must manage its fisc better

Curve tracks intersection of inequality with how likely it is for next generation to move up economic ladder. Big Latin American economies are worst at that.

Death and journalism: India’s Covid deaths are undercounted, but twice the Partition toll?

Last 3 months have been gravest period of national tragedy, and a lot of Indians have died, mostly avoidably. But an undercount of total deaths at a mass scale is tougher.

Supreme Court to hear plea seeking cancellation of Class 12 boards on 31 May

The plea contended that the unprecedented surge in Covid has made it impossible to conduct the exams and any further delay would cause irreparable loss to the students' future.

It takes 4 months to manufacture, release a batch of Covaxin, says Bharat Biotech

Bharat Biotech’s statement comes at a time when the country is facing a shortage of Covid vaccines, leading to disruptions in the nationwide inoculation programme.

BKU (Ugrahan) begins 3-day protest over Punjab govt’s failure to tackle Covid

A BKU (U) leader alleged that the Modi govt had also failed to deal with the Covid situation and some BJP leaders were now shifting blame on farmers to defame their agitation.

On Camera

You can’t ‘wish away’ China, India must balance economic & security considerations, says Sanjeev Sanyal

Sanyal, an economist & member of the Economic Advisory Council to PM, also suggests that if India is to import parts from China, why not allow Chinese companies to manufacture in India.

Compete, coexist, confront & contest: Army chief General Dwivedi says on dealing with China

Referring to current situation, General Upendra Dwivedi says it is stable but not normal; instead, sensitive. He adds the diplomatic side can only come up with certain options.

Islam doesn’t kill democracy. The army-Islam combo does

How come Indonesia, Malaysia, Turkey and Sri Lanka remain constitutional, democratic and stable despite Islam and Buddhism respectively, but Pakistan, Bangladesh and Myanmar don’t?